Navigating uncharted waters: Developing a standardized approach for evaluating and implementing biosimilar products at a comprehensive cancer center
Purpose: The processes for formulary implementation and electronic health record (EHR) integration of biosimilar products at a comprehensive cancer center are described. Implications for research protocols are also discussed. Summary: The existing literature focuses on practical considerations for f...
Main Authors: | Davis, J.E (Author), Sobocinski, S.M (Author), Villanueva, M.N (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Real-world evidence of a successful biosimilar adoption program
by: Humphreys, S.Z
Published: (2022) -
Considerations for the US health-system pharmacist in a world of biosimilars
by: Andrea Zlatkus, et al.
Published: (2020-02-01) -
Main concepts on bioequivalence and biosimilarity in the Chilean legislation, and current controversies on drug interchangeability
by: Jana Stojanova, et al.
Published: (2020-01-01) -
Biosimilars in the management of neutropenia: focus on filgrastim
by: Caselli D, et al.
Published: (2016-02-01) -
Biosimilars in rheumatology and other fields of medicine
by: Marcin Milchert, et al.
Published: (2014-07-01)